- FILTERS Advanced
- Product Type
- Application
- Species / Reactivity
- Conjugation
- CE / IVD
- EXCLUDE FILTERS
- Application
- Species / Reactivity
- Conjugation
| Name | Art no | Species Reactivity | Application | Conjugation | Purity | Source / Host | Size | Price |
|---|---|---|---|---|---|---|---|---|
|
CY-E1248
|
mammals
|
|
|
> 90 % as determined by SDS PAGE
|
|
10 µg
|
||
|
CY-E1168-1
|
|
|
|
>85% pure as determined by SDS-PAGE analysis.
|
|
200 Assays
|
||
|
CY-E1168-2
|
|
|
|
>90% pure as determined by SDS-PAGE analysis.
|
|
200 Assays
|
||
|
4696-100
|
|
FC
|
|
|
|
500 µl
|
||
|
CY-E1174-2
|
|
|
|
Aurora B is greater than 85% pure as determined by
SDS-PAGE analysis.
|
|
200 Assays
|
||
|
CY-E1170-1
|
|
|
|
>65% pure as determined by SDS-PAGE analysis.
|
|
200 Assays
|
||
|
CY-E1173
|
|
|
|
>90% pure as determined by SDS-PAGE analysis.
|
|
200 Assays
|
||
|
CY-E1185-2
|
|
|
|
greater than 85%
|
|
200 Assays
|
||
|
SPC040
|
human
|
|
|
|
|
1 mg
|
||
|
SPC059
|
human
|
|
|
|
|
1 mg
|
||
|
SPC058
|
human
|
|
|
|
|
1 mg
|
||
|
SPC060
|
human
|
|
|
|
|
1 mg
|
||
|
SPC057
|
human
|
|
|
|
|
1 mg
|
||
|
SPC056
|
human
|
|
|
|
|
1 mg
|
||
|
CY-R2054
|
|
ELISA
|
|
|
|
200 µg
|
||
|
CY-R2067
|
|
ELISA
|
|
|
|
200 µg
|
||
|
CY-R2052
|
|
ELISA
|
|
|
|
200 µg
|
||
|
CY-R2066
|
|
ELISA
|
|
|
|
200 µg
|
||
|
CY-R2056
|
|
ELISA
|
|
|
|
200 µg
|
||
|
CY-R2058
|
|
ELISA
|
|
|
|
200 µg
|
||
|
CY-R2060
|
|
ELISA
|
|
|
|
200 µg
|
||
|
CY-R2270
|
human
|
ELISA
|
|
|
|
50 µg
|
||
|
CY-R2269
|
human
|
ELISA
|
|
|
|
100 µg
|
||
|
CY-R2263
|
human
|
ELISA
|
|
Purity is over 90 % estimated by SDS-PAGE analysis.
|
|
100 µg
|
||
|
CY-R2252
|
human
|
ELISA
|
|
Purity is over 90 % estimated by SDS-PAGE analysis.
|
|
100 µg
|
||
|
CY-R2257
|
human
|
ELISA
|
|
|
|
100 µg
|
||
|
CY-R2258
|
human
|
ELISA
|
|
|
|
100 µg
|
||
|
CY-R2259-G
|
human
|
ELISA
|
|
|
|
100 µg
|
||
|
CY-R2250
|
human
|
ELISA
|
|
|
|
100 µg
|
||
|
CY-R2267
|
human
|
ELISA
|
|
|
|
100 µg
|
||
|
CY-R2340
|
|
ELISA
|
|
The LDLR EGF-AB domain is greater than 90 % pure as determined by SDS-PAGE analysis.
|
|
50 µg
|
||
|
CY-R2062
|
|
ELISA
|
|
|
|
200 µg
|
||
|
CY-R2331
|
|
ELISA
|
|
The PCSK9 D374Y is greater than 95 % pure as determined by SDS-PAGE analysis.
|
|
10 µg
|
||
|
CY-R2311
|
|
ELISA
|
|
|
|
50 µg
|
||
|
CY-R2333
|
human
|
ELISA
|
|
The PCSK9 R194A is greater than 95 % pure as determined by SDS-PAGE analysis.
|
|
20 µg
|
||
|
CY-R2330
|
|
ELISA
|
|
The PCSK9 Wild Type is greater than 95 % pure as determined by SDS-PAGE analysis.
|
|
50 µg
|
||
|
CY-E1178-2
|
|
|
|
IKKβ is greater than 85% pure as determined by SDS-PAGE analysis.
|
|
200 Assays
|
||
|
3326KR
|
|
Protein Purification
|
|
|
|
1 mL
|
||
|
TS-M813-P
|
|
FC
|
PE
|
|
|
100 uL (10 mg/ mL)
|
||
|
TS-M811-P
|
|
FC
|
PE
|
|
|
100 uL (10 mg/ mL)
|
||
|
TS-M814-P
|
|
FC
|
PE
|
|
|
100 uL (10 mg/ mL)
|
||
|
TS-M818-P
|
|
FC
|
|
|
|
100 uL (10 mg/ mL)
|
||
|
TS-M151-P
|
human
|
FC
|
|
|
|
100 uL (10 mg/ mL)
|
||
|
TS-M069-P
|
human
|
FC
|
|
|
|
100 µL (10 mg/mL)
|
||
|
TS-M026-P
|
human
|
FC
|
|
|
|
100 µL (10 mg/mL)
|
||
|
TS-M140-P
|
human
|
FC
|
|
|
|
100 µL (10 mg/mL)
|
||
|
TS-M152-P
|
human
|
FC
|
|
|
|
100 uL (10 mg/ mL)
|
||
|
TS-M135-P
|
human
|
FC
|
|
|
|
100 µL (10 mg/mL)
|
||
|
TS-M153-P
|
human
|
FC
|
|
|
|
100 uL (10 mg/ mL)
|
||
|
TS-M003-P
|
human
|
FC
|
|
|
|
100 µL (10 mg/mL)
|
